cDNA accession Links to the sequence |
Tissue most 5' clones in red |
Match mRNA |
From bp to bp in mRNA |
From bp to bp in accs. |
Clone encodes complete protein (with AA variation) |
Features | Anomalies detected by AceView |
Accession match over (% length) |
Base differences relative to genome (% identity) |
AA367181 | Pancreas | .a | 1712 to 1932 | 1 to 221 | 221/221 (100 %) | 0 diff (100 %id) | |||
AK001500 | .a | 60 to 2674 | 1 to 2615 | tiling clone, available from FLJ, | 2615/2615 (100 %) | 5 diff (99.9 %id) | |||
AK023914 | thyroid gland | .a | 37 to 2368 | 1 to 2331 | tiling clone, available from FLJ, | 2331/2331 (100 %) | 2 diff (100.0 %id) | ||
AK225404 | Kidney | .a | 48 to 976 | 1 to 929 | 929/929 (100 %) | 1 diff (99.9 %id) | |||
AK294615 | brain | .b | 1 to 1324 | 1 to 1324 | K131N | tiling clone, | 1324/1324 (100 %) | 1 diff (100.0 %id) | |
AK295444 | corpus callosum | .d | 1 to 985 | 1 to 985 | V83M | tiling clone, | 985/985 (100 %) | 2 diff (99.8 %id) | |
AK301225 | Spleen | .c | 1 to 1000 | 1 to 1000 | exact | tiling clone, | 1000/1000 (100 %) | 0 diff (100 %id) | |
AL833857 | amygdala | .a | 153 to 2533 | 1 to 2381 | tiling clone, available from DKFZ, AAA | 2381/2381 (100 %) | 3 diff (99.9 %id) | ||
DA021845 | .a | 60 to 624 | 2 to 566 | capped | 565/565 (100 %) | 1 diff (99.9 %id) | |||
DA029501 | .a | 35 to 606 | 2 to 573 | capped | 572/572 (100 %) | 3 diff (99.5 %id) | |||
DA030886 | .a | 37 to 592 | 2 to 557 | capped | 556/556 (100 %) | 2 diff (99.7 %id) | |||
AW862115 | colon | .a | 659 to 1067 | 412 to 8 | 405/412 (98 %) | 1 diff (99.8 %id) | |||
AW934982 | denis_drash | .f | 6 to 353 | 347 to 1 | tiling clone, | Submitted on the opposite strand | 347/347 (100 %) | 6 diff (98.3 %id) | |
AW966088 | .a | 1713 to 1905 | 1 to 193 | 193/333 (57 %) | 1 diff (99.7 %id) | ||||
CB152789 | brain | .a | 183 to 499 | 1 to 317 | 317/317 (100 %) | 2 diff (99.4 %id) | |||
CB153340 | brain | .a | 183 to 689 | 1 to 507 | 507/507 (100 %) | 2 diff (99.7 %id) | |||
BC007993 | Lung, small cell carcinoma | .a | 17 to 1175 | 1 to 1159 | K162N | available from MGC, AAA | 1159/1159 (100 %) | 1 diff (100.0 %id) | |
DA047008 | .a | 49 to 822 | 2 to 775 | capped | 774/775 (99 %) | 16 diff (98.0 %id) | |||
DA049079 | .a | 38 to 670 | 2 to 634 | capped | 633/633 (100 %) | 1 diff (99.9 %id) | |||
DA050050 | .a | 38 to 607 | 2 to 571 | capped | 570/570 (100 %) | 1 diff (99.9 %id) | |||
DA052658 | .a | 49 to 614 | 2 to 568 | capped | 567/567 (100 %) | 2 diff (99.7 %id) | |||
DA123983 | cerebellum | .f | 1 to 509 | 2 to 510 | exact | tiling clone, capped | 509/509 (100 %) | 1 diff (99.9 %id) | |
DA129069 | alzheimer cortex | .a | 38 to 596 | 2 to 560 | capped | 559/559 (100 %) | 0 diff (100 %id) | ||
DA137699 | alzheimer cortex | .g | 12 to 578 | 2 to 568 | capped | 567/567 (100 %) | 0 diff (100 %id) | ||
DA137906 | alzheimer cortex | .a | 38 to 589 | 2 to 553 | capped | 552/552 (100 %) | 0 diff (100 %id) | ||
DA147138 | amygdala | .a | 58 to 624 | 2 to 568 | capped | 567/567 (100 %) | 1 diff (99.9 %id) | ||
DA164454 | amygdala | .a | 58 to 616 | 2 to 561 | capped | 560/560 (100 %) | 2 diff (99.7 %id) | ||
DA169863 | amygdala | .a | 58 to 613 | 2 to 557 | capped | 556/556 (100 %) | 1 diff (99.9 %id) | ||
DA197320 | brain | .a | 28 to 708 | 2 to 681 | capped | 680/681 (99 %) | 8 diff (98.9 %id) | ||
DB303756 | brain | .a | 1988 to 2527 | 546 to 1 | 546/550 (99 %) | 28 diff (95.0 %id) | |||
DA198297 | brain | .g | 1 to 558 | 2 to 560 | tiling clone, capped | 559/559 (100 %) | 2 diff (99.7 %id) | ||
DA199877 | brain | .a | 49 to 610 | 2 to 563 | capped | 562/562 (100 %) | 2 diff (99.7 %id) | ||
DC319199 | brain | .b | 1 to 556 | 1 to 556 | 556/556 (100 %) | 0 diff (100 %id) | |||
DA202605 | brain | .a | 58 to 624 | 2 to 568 | capped | 567/567 (100 %) | 2 diff (99.7 %id) | ||
DA264446 | caudate nucleus | .a | 49 to 601 | 2 to 554 | capped | 553/553 (100 %) | 0 diff (100 %id) | ||
DA272977 | caudate nucleus | .e | 1 to 563 | 3 to 565 | capped | 564/564 (100 %) | 1 diff (99.9 %id) | ||
DA279297 | corpus callosum | .a | 24 to 585 | 2 to 563 | capped | 562/562 (100 %) | 1 diff (99.9 %id) | ||
DA282329 | corpus callosum | .a | 61 to 632 | 2 to 573 | capped | 572/572 (100 %) | 1 diff (99.9 %id) | ||
DC329745 | corpus callosum | .d | 1 to 555 | 1 to 556 | 556/556 (100 %) | 4 diff (99.3 %id) | |||
DA291476 | hippocampus | .a | 58 to 630 | 2 to 574 | capped | 573/573 (100 %) | 1 diff (99.9 %id) | ||
DA294291 | hippocampus | .a | 58 to 629 | 2 to 573 | capped | 572/572 (100 %) | 1 diff (99.9 %id) | ||
DA303210 | hippocampus | .a | 37 to 617 | 2 to 583 | capped | 582/582 (100 %) | 2 diff (99.7 %id) | ||
DA376226 | thalamus | .a | 58 to 614 | 2 to 558 | capped | 557/557 (100 %) | 1 diff (99.9 %id) | ||
DA388645 | thalamus | .a | 58 to 624 | 2 to 568 | capped | 567/567 (100 %) | 1 diff (99.9 %id) | ||
DA403767 | thalamus | .a | 1 to 514 | 5 to 518 | capped | 517/517 (100 %) | 1 diff (99.9 %id) | ||
BX090411 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .a | 1648 to 2302 | 1 to 656 | 656/656 (100 %) | 2 diff (99.7 %id) | |||
BP212484 | cerebrum | .a | 27 to 610 | 1 to 585 | 585/585 (100 %) | 3 diff (99.5 %id) | |||
CN256374 | embryonic stem cells, DMSO-treated H9 cellline | .a | 75 to 364 | 1 to 290 | 290/290 (100 %) | 0 diff (100 %id) | |||
AL519337 | brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized | .a | 1286 to 2339 | 1054 to 1 | 1054/1058 (99 %) | 19 diff (98.3 %id) | |||
AL519338 | brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized | .a | 56 to 1060 | 1 to 994 | 994/1004 (99 %) | 13 diff (98.8 %id) | |||
BX352919 | Neuroblastoma Cot 10-normalized | .a | 51 to 1120 | 1 to 1067 | 1067/1067 (100 %) | 19 diff (98.3 %id) | |||
AL522084 | brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized | .a | 1594 to 2295 | 734 to 33 | 702/734 (95 %) | 0 diff (100 %id) | |||
AL522085 | brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized | .a | 48 to 752 | 1 to 705 | 705/705 (100 %) | 2 diff (99.8 %id) | |||
AL525110 | brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized | .a | 1462 to 2298 | 862 to 26 | 837/862 (97 %) | 0 diff (100 %id) | |||
AL525111 | brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized | .a | 44 to 855 | 1 to 811 | 811/811 (100 %) | 3 diff (99.7 %id) | |||
AL526199 | brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized | .a | 1522 to 2502 | 978 to 1 | 978/978 (100 %) | 7 diff (99.3 %id) | |||
AL526237 | brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized | .a | 48 to 964 | 1 to 914 | 914/914 (100 %) | 4 diff (99.6 %id) | |||
AL556719 | placenta | .a | 52 to 617 | 1 to 566 | 566/566 (100 %) | 18 diff (96.9 %id) | |||
AL578917 | placenta | .a | 1352 to 2336 | 977 to 1 | 977/1023 (95 %) | 29 diff (97.2 %id) | |||
BX370424 | .a | 397 to 1340 | 1 to 945 | 945/956 (98 %) | 63 diff (93.5 %id) | ||||
DA434117 | tongue, tumor tissue | .a | 63 to 587 | 2 to 526 | capped | 525/525 (100 %) | 1 diff (99.9 %id) | ||
DA441000 | tongue, tumor tissue | .a | 58 to 616 | 2 to 560 | capped | 559/559 (100 %) | 1 diff (99.9 %id) | ||
DA441277 | tongue, tumor tissue | .a | 58 to 642 | 2 to 586 | capped | 585/585 (100 %) | 1 diff (99.9 %id) | ||
CV027129 | mixed | .a | 63 to 724 | 1 to 662 | 662/662 (100 %) | 1 diff (99.9 %id) | |||
DA474930 | .a | 58 to 606 | 2 to 550 | capped | 549/549 (100 %) | 1 diff (99.9 %id) | |||
AL706316 | human skeletal muscle | .a | 46 to 647 | 1 to 602 | 602/602 (100 %) | 17 diff (97.2 %id) | |||
DT217518 | brain | .a | 880 to 1461 | 1 to 582 | 582/582 (100 %) | 0 diff (100 %id) | |||
EC457831 | Prostate | .a | 993 to 1085 | 108 to 17 | 92/108 (85 %) | 0 diff (100 %id) | |||
EC511005 | Prostate | .a | 1095 to 1191 | 97 to 1 | 97/97 (100 %) | 0 diff (100 %id) | |||
EC539900 | Prostate | .a | 2232 to 2336 | 1 to 104 | 104/104 (100 %) | 1 diff (99.1 %id) | |||
EC540497 | Prostate | .a | 1095 to 1188 | 94 to 3 | 92/94 (97 %) | 0 diff (100 %id) | |||
EC542040 | Prostate | .a | 2263 to 2347 | 85 to 1 | 85/85 (100 %) | 2 diff (97.7 %id) | |||
EC574669 | Prostate | .a | 1574 to 1665 | 92 to 2 | 91/104 (87 %) | 0 diff (100 %id) | |||
DA481826 | .g | 12 to 590 | 2 to 580 | tiling clone, capped | 579/579 (100 %) | 1 diff (99.9 %id) | |||
DA482855 | .a | 201 to 781 | 2 to 582 | capped | 581/581 (100 %) | 2 diff (99.7 %id) | |||
DA503732 | brain | .a | 36 to 578 | 2 to 544 | capped | 543/543 (100 %) | 1 diff (99.9 %id) | ||
DA524450 | brain | .a | 58 to 618 | 2 to 562 | capped | 561/561 (100 %) | 1 diff (99.9 %id) | ||
CD673994 | eye, lens | .a | 72 to 624 | 1 to 553 | 553/553 (100 %) | 1 diff (99.9 %id) | |||
BP395204 | pancreatic islet | .a | 1995 to 2166 | 1 to 174 | Submitted on the opposite strand | 174/185 (94 %) | 3 diff (98.4 %id) | ||
DA547984 | .a | 58 to 617 | 2 to 561 | capped | 560/561 (99 %) | 3 diff (99.5 %id) | |||
DA553613 | .a | 58 to 617 | 2 to 561 | capped | 560/564 (99 %) | 3 diff (99.5 %id) | |||
DA557487 | .a | 47 to 609 | 2 to 564 | capped | 563/563 (100 %) | 1 diff (99.9 %id) | |||
DA567684 | .a | 58 to 569 | 2 to 513 | capped | 512/512 (100 %) | 1 diff (99.9 %id) | |||
M79243 | .a | 1856 to 2175 | 320 to 1 | 320/320 (100 %) | 3 diff (99.1 %id) | ||||
DA579273 | .a | 37 to 579 | 2 to 544 | capped | 543/543 (100 %) | 0 diff (100 %id) | |||
DA585129 | lung | .a | 59 to 581 | 2 to 525 | capped | 524/524 (100 %) | 3 diff (99.5 %id) | ||
BP254227 | Kidney | .a | 48 to 629 | 1 to 582 | 582/582 (100 %) | 1 diff (99.9 %id) | |||
H27219 | breast | .a | 1779 to 1991 | 1 to 212 | 212/212 (100 %) | 3 diff (98.6 %id) | |||
AF086378 | .a | 1647 to 2348 | 1 to 702 | AAA | 702/702 (100 %) | 0 diff (100 %id) | |||
W72182 | heart | .a | 1789 to 2349 | 562 to 3 | 560/564 (99 %) | 0 diff (100 %id) | |||
W77818 | heart | .a | 1647 to 2098 | 1 to 452 | 452/452 (100 %) | 4 diff (99.2 %id) | |||
AA025026 | heart | .a | 1807 to 1988 | 11 to 192 | 182/192 (94 %) | 5 diff (97.4 %id) | |||
AA025027 | heart | .a | 1991 to 2356 | 378 to 12 | AAA | 367/456 (80 %) | 2 diff (99.6 %id) | ||
AA242755 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .a | 1991 to 2349 | 360 to 3 | fully sequenced, | 358/360 (99 %) | 0 diff (100 %id) | ||
AA242895 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .a | 1646 to 1992 | 1 to 345 | fully sequenced, | 345/345 (100 %) | 3 diff (99.2 %id) | ||
AA421711 | ovarian tumor, ovary | .a | 1891 to 2352 | 1 to 461 | 461/461 (100 %) | 3 diff (99.4 %id) | |||
AA411264 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .a | 1642 to 2054 | 8 to 420 | fully sequenced, | 413/420 (98 %) | 7 diff (98.4 %id) | ||
AA436257 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .a | 2024 to 2349 | 329 to 3 | fully sequenced, | 327/329 (99 %) | 0 diff (100 %id) | ||
AA639773 | colon, colon tumor RER+ | .a | 2199 to 2348 | 181 to 33 | AAA | 149/149 (100 %) | 1 diff (99.4 %id) | ||
AA909875 | pooled | .a | 1991 to 2357 | 368 to 3 | 366/368 (99 %) | 0 diff (100 %id) | |||
AA926737 | pooled | .a | 2061 to 2527 | 467 to 1 | 467/467 (100 %) | 1 diff (99.8 %id) | |||
AI358106 | moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus | .a | 1958 to 2356 | 399 to 1 | 399/399 (100 %) | 0 diff (100 %id) | |||
AI919425 | anaplastic oligodendroglioma, brain | .a | 2041 to 2357 | 316 to 1 | 316/316 (100 %) | 1 diff (99.7 %id) | |||
AI683170 | uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors | .a | 2136 to 2528 | 397 to 5 | 393/397 (98 %) | 0 diff (100 %id) | |||
AI797700 | pooled | .a | 1815 to 2349 | 538 to 4 | 535/538 (99 %) | 0 diff (100 %id) | |||
AI860931 | anaplastic oligodendroglioma, brain | .a | 1922 to 2357 | 437 to 2 | 436/437 (99 %) | 0 diff (100 %id) | |||
AI886973 | anaplastic oligodendroglioma, brain | .a | 2220 to 2348 | 154 to 26 | AAA | 129/129 (100 %) | 1 diff (99.3 %id) | ||
AI963473 | adenocarcinoma, Pancreas | .a | 583 to 1174 | 591 to 1 | 591/664 (89 %) | 3 diff (99.6 %id) | |||
AW129018 | brain, tumor, 5 pooled (see description) | .a | 2040 to 2348 | 323 to 16 | AAA | 308/308 (100 %) | 1 diff (99.7 %id) | ||
AW207706 | .a | 1978 to 2351 | 391 to 18 | AAA | 374/374 (100 %) | 1 diff (99.8 %id) | |||
AW449827 | .a | 1988 to 2351 | 381 to 18 | AAA | 364/364 (100 %) | 1 diff (99.8 %id) | |||
BF508350 | .a | 1913 to 2351 | 456 to 18 | AAA | 439/439 (100 %) | 2 diff (99.6 %id) | |||
BF063551 | colon, colon tumor, RER+ | .a | 2251 to 2353 | 105 to 3 | 103/105 (98 %) | 0 diff (100 %id) | |||
BE267359 | lung, small cell carcinoma | .a | 35 to 677 | 1 to 639 | 639/744 (85 %) | 18 diff (97.6 %id) | |||
BF436852 | Prostate | .a | 1835 to 2353 | 521 to 3 | 519/521 (99 %) | 0 diff (100 %id) | |||
BE563597 | adenocarcinoma, Pancreas | .a | 684 to 1331 | 1 to 660 | 660/670 (98 %) | 14 diff (98.0 %id) | |||
BE786498 | large cell carcinoma, lung | .a | 1852 to 2350 | 1 to 493 | 493/493 (100 %) | 6 diff (98.8 %id) | |||
BE621964 | melanotic melanoma, skin | .a | 772 to 1369 | 1 to 595 | 595/595 (100 %) | 3 diff (99.5 %id) | |||
BF530432 | anaplastic oligodendroglioma with 1p/19qloss, brain | .a | 1881 to 2348 | 36 to 502 | AAA | 467/502 (93 %) | 6 diff (98.9 %id) | ||
BF797243 | lymph, lymphoma, cell line | .a | 502 to 1290 | 1 to 781 | 781/895 (87 %) | 45 diff (95.0 %id) | |||
BG168044 | hypernephroma, cell line, Kidney | .a | 1727 to 2351 | 1 to 625 | AAA | 625/625 (100 %) | 3 diff (99.6 %id) | ||
BG282890 | adenocarcinoma, cell line, Prostate | .a | 59 to 648 | 1 to 590 | 590/590 (100 %) | 6 diff (99.0 %id) | |||
BG393676 | embryonal carcinoma, cell line, testis | .a | 376 to 1055 | 1 to 679 | 679/679 (100 %) | 6 diff (99.2 %id) | |||
BG912378 | anaplastic oligodendroglioma with 1p/19qloss, brain | .a | 1680 to 2429 | 1 to 749 | 749/750 (99 %) | 5 diff (99.4 %id) | |||
BI084245 | epidermoid carcinoma, cell line, salivary gland | .a | 1427 to 2057 | 1 to 638 | 638/638 (100 %) | 22 diff (96.6 %id) | |||
BI253559 | cervical carcinoma cell line, cervix | .a | 71 to 792 | 13 to 734 | 722/734 (98 %) | 13 diff (98.3 %id) | |||
BI254417 | cervical carcinoma cell line, cervix | .a | 38 to 799 | 8 to 787 | 752/788 (95 %) | 46 diff (94.2 %id) | |||
BI827333 | brain, medulla | .a | 44 to 817 | 1 to 773 | 773/773 (100 %) | 3 diff (99.7 %id) | |||
BI818555 | pooled brain, lung, testis | .a | 37 to 803 | 1 to 772 | 772/773 (99 %) | 24 diff (96.9 %id) | |||
BI837148 | pooled pancreas and spleen | .a | 50 to 923 | 1 to 872 | 872/873 (99 %) | 12 diff (98.7 %id) | |||
BM014974 | breast, mammary adenocarcinoma, cell line | .a | 50 to 900 | 1 to 853 | 853/856 (99 %) | 18 diff (97.9 %id) | |||
BM019985 | astrocytoma grade IV, cell line, brain | .a | 661 to 1469 | 1 to 823 | 823/823 (100 %) | 32 diff (96.2 %id) | |||
BM010281 | amelanotic melanoma, cell line, skin | .a | 42 to 781 | 1 to 741 | 741/741 (100 %) | 21 diff (97.2 %id) | |||
BM048317 | carcinoma, cell line, Prostate | .a | 1783 to 2348 | 1 to 566 | AAA | 566/566 (100 %) | 1 diff (99.9 %id) | ||
BM012657 | brain, neuroblastoma, cell line | .a | 934 to 1498 | 1 to 563 | 563/564 (99 %) | 3 diff (99.5 %id) | |||
BM465183 | eye, retinoblastoma | .a | 56 to 693 | 1 to 644 | 644/1024 (62 %) | 13 diff (98.8 %id) | |||
BM424026 | amelanotic melanoma, cell line, skin | .a | 43 to 617 | 1 to 577 | 577/1132 (50 %) | 13 diff (98.9 %id) | |||
BM473687 | duodenal adenocarcinoma, cell line, small intestine | .a | 57 to 708 | 1 to 652 | 652/1145 (56 %) | 7 diff (99.4 %id) | |||
BM545513 | brain, hippocampus | .a | 13 to 705 | 1 to 697 | 697/1036 (67 %) | 10 diff (99.1 %id) | |||
BM548059 | brain, hippocampus | .a | 53 to 1056 | 25 to 1040 | 1016/1086 (93 %) | 37 diff (96.6 %id) | |||
BM808550 | brain, hippocampus | .e | 20 to 832 | 5 to 821 | tiling clone, | 817/966 (84 %) | 16 diff (98.4 %id) | ||
BM809000 | brain, hippocampus | .a | 982 to 1576 | 1 to 595 | 595/1220 (48 %) | 12 diff (99.1 %id) | |||
BM563669 | brain, medulla | .e | 1 to 712 | 6 to 727 | V105M | tiling clone, | 727/1116 (65 %) | 12 diff (99.0 %id) | |
BM923064 | leukocyte | .a | 39 to 1090 | 6 to 1078 | 1073/1080 (99 %) | 64 diff (94.1 %id) | |||
BM923232 | pooled colon, kidney, stomach | .a | 1039 to 1905 | 1 to 871 | 871/1044 (83 %) | 14 diff (98.7 %id) | |||
BQ053960 | blood, natural killer cells, cell line | .a | 1274 to 1899 | 1 to 629 | 629/1147 (54 %) | 5 diff (99.6 %id) | |||
CB216740 | normal endometrium, mid-secretory phase,cycle day 23, uterus | .a | 1316 to 1877 | 1 to 562 | 562/562 (100 %) | 0 diff (100 %id) | |||
BU181305 | large cell carcinoma, lung | .a | 40 to 846 | 1 to 814 | 814/884 (92 %) | 20 diff (97.8 %id) | |||
BQ777261 | Pancreas, Purified pancreatic islet | .a | 1585 to 1959 | 1 to 375 | fully sequenced, | 375/375 (100 %) | 3 diff (99.2 %id) | ||
BQ787958 | Pancreas, Purified pancreatic islet | .a | 1929 to 2353 | 425 to 1 | fully sequenced, | 425/425 (100 %) | 4 diff (99.1 %id) | ||
BQ436653 | melanotic melanoma, skin | .a | 74 to 822 | 1 to 755 | 755/932 (81 %) | 17 diff (98.2 %id) | |||
BQ877908 | epidermoid carcinoma, cell line, salivary gland | .a | 1432 to 1896 | 1 to 466 | 466/466 (100 %) | 1 diff (99.8 %id) | |||
BU172522 | melanotic melanoma, skin | .a | 51 to 742 | 4 to 704 | 701/890 (78 %) | 21 diff (97.7 %id) | |||
BQ898166 | epidermoid carcinoma, cell line, salivary gland | .a | 1431 to 1893 | 1 to 463 | 463/468 (98 %) | 4 diff (99.2 %id) | |||
BQ671476 | epidermoid carcinoma, cell line, salivary gland | .a | 1429 to 1897 | 21 to 488 | 468/491 (95 %) | 4 diff (99.2 %id) | |||
BU502774 | carcinoma, cell line, Prostate | .a | 1452 to 1987 | 26 to 566 | 541/1168 (46 %) | 6 diff (99.5 %id) | |||
CX788717 | human embryonic stem cells | .a | 1889 to 2647 | 1 to 759 | 759/759 (100 %) | 1 diff (99.9 %id) | |||
CV813307 | Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass | .a | 799 to 1472 | 1 to 674 | 674/675 (99 %) | 9 diff (98.7 %id) | |||
CF145400 | CNCAP(3)T-225 cell line, Prostate | .a | 216 to 805 | 1 to 590 | 590/590 (100 %) | 5 diff (99.2 %id) | |||
CF146807 | CNCAP(3)T-225 cell line, Prostate | .a | 2265 to 2533 | 2 to 271 | AAA | 270/271 (99 %) | 6 diff (97.8 %id) | ||
CF146838 | CNCAP(3)T-225 cell line, Prostate | .a | 2265 to 2533 | 2 to 271 | AAA | 270/271 (99 %) | 6 diff (97.8 %id) | ||
DA606968 | .a | 993 to 1469 | 2 to 478 | capped | 477/477 (100 %) | 1 diff (99.8 %id) | |||
TI_57196449 | .a | 33 to 803 | 32 to 807 | 776/808 (96 %) | 29 diff (96.5 %id) | ||||
TI_57174759 | .a | 44 to 817 | 28 to 800 | 773/800 (96 %) | 11 diff (98.7 %id) | ||||
TI_57167827 | .a | 44 to 923 | 30 to 907 | 878/908 (96 %) | 17 diff (98.2 %id) | ||||
TI_59385088 | .a | 43 to 781 | 63 to 802 | 740/740 (100 %) | 20 diff (97.3 %id) | ||||
TI_59381879 | .a | 935 to 1498 | 70 to 631 | 562/563 (99 %) | 3 diff (99.5 %id) | ||||
TI_59393071 | .a | 50 to 900 | 91 to 943 | 853/856 (99 %) | 18 diff (97.9 %id) | ||||
TI_59390761 | .a | 662 to 1469 | 133 to 954 | 822/822 (100 %) | 31 diff (96.3 %id) | ||||
DA621230 | Kidney | .a | 49 to 607 | 2 to 560 | capped | 559/559 (100 %) | 0 diff (100 %id) | ||
DA629534 | Kidney | .a | 1 to 571 | 3 to 573 | tiling clone, capped | 572/572 (100 %) | 0 diff (100 %id) | ||
DA648694 | .a | 38 to 577 | 2 to 541 | capped | 540/540 (100 %) | 1 diff (99.9 %id) | |||
DA651487 | .a | 38 to 577 | 2 to 546 | capped | 545/548 (99 %) | 8 diff (98.6 %id) | |||
DA655463 | .a | 47 to 609 | 2 to 564 | capped | 563/563 (100 %) | 1 diff (99.9 %id) | |||
DA661652 | .a | 35 to 594 | 2 to 565 | capped | 564/564 (100 %) | 5 diff (99.2 %id) | |||
AU280528 | .a | 55 to 614 | 1 to 560 | 560/560 (100 %) | 1 diff (99.9 %id) | ||||
NM_023078.3 | .a | 1 to 2674 | 5 to 2678 | exact | RefSeq, | 2678/2678 (100 %) | 0 diff (100 %id) | ||
AU129509 | .a | 61 to 611 | 2 to 557 | capped | 556/562 (98 %) | 15 diff (97.4 %id) | |||
AU151610 | .a | 2096 to 2674 | 573 to 1 | 573/580 (98 %) | 37 diff (93.7 %id) | ||||
DA738571 | .a | 17 to 708 | 2 to 694 | capped | 693/717 (96 %) | 6 diff (99.2 %id) | |||
DB324539 | .a | 2163 to 2674 | 512 to 1 | 512/519 (98 %) | 14 diff (97.4 %id) | ||||
DA777535 | brain | .a | 1 to 576 | 3 to 578 | capped | 577/577 (100 %) | 1 diff (99.9 %id) | ||
DA780432 | brain | .a | 1 to 572 | 2 to 573 | capped | 572/572 (100 %) | 1 diff (99.9 %id) | ||
DA876297 | Prostate | .a | 37 to 601 | 2 to 566 | capped | 565/565 (100 %) | 1 diff (99.9 %id) | ||
DA886321 | .a | 60 to 626 | 2 to 568 | capped | 567/567 (100 %) | 0 diff (100 %id) | |||
BP331008 | rectum | .a | 45 to 625 | 1 to 581 | 581/581 (100 %) | 1 diff (99.9 %id) | |||
TI_1948102508 | .a | 63 to 769 | 128 to 841 | fully sequenced, | 714/841 (84 %) | 38 diff (95.5 %id) | |||
TI_1948102509 | .a | 739 to 886 | 211 to 64 | fully sequenced, | 148/175 (84 %) | 0 diff (100 %id) | |||
TI_1948102674 | .a | 63 to 577 | 128 to 642 | fully sequenced, | 515/642 (80 %) | 8 diff (98.8 %id) | |||
TI_1948102675 | .a | 547 to 886 | 406 to 66 | fully sequenced, | 341/406 (83 %) | 0 diff (100 %id) | |||
F35951 | pectoral muscle (after mastectomy) | .a | 2082 to 2356 | 1 to 275 | AAA | 275/275 (100 %) | 2 diff (99.3 %id) | ||
DA901489 | .a | 38 to 554 | 2 to 518 | capped | 517/517 (100 %) | 0 diff (100 %id) | |||
DA901807 | .a | 49 to 552 | 2 to 507 | capped | 506/506 (100 %) | 2 diff (99.7 %id) | |||
DA904650 | .a | 49 to 612 | 2 to 565 | capped | 564/564 (100 %) | 0 diff (100 %id) | |||
DA905499 | .a | 55 to 620 | 14 to 579 | capped | 566/566 (100 %) | 0 diff (100 %id) | |||
DA918175 | small intestine | .a | 1 to 511 | 3 to 513 | capped | 512/515 (99 %) | 1 diff (99.9 %id) | ||
DA919818 | small intestine | .a | 28 to 588 | 2 to 562 | capped | 561/561 (100 %) | 1 diff (99.9 %id) | ||
DA920688 | small intestine | .a | 46 to 615 | 2 to 571 | capped | 570/570 (100 %) | 1 diff (99.9 %id) | ||
DA941030 | Spleen | .a | 43 to 623 | 2 to 582 | capped | 581/581 (100 %) | 1 diff (99.9 %id) | ||
DA945375 | Spleen | .a | 1 to 544 | 5 to 548 | capped | 547/547 (100 %) | 0 diff (100 %id) | ||
DA948173 | Spleen | .a | 28 to 598 | 2 to 574 | capped | 573/573 (100 %) | 3 diff (99.5 %id) | ||
DC391258 | Spleen | .c | 1 to 578 | 1 to 578 | 578/578 (100 %) | 0 diff (100 %id) | |||
BP353426 | .a | 37 to 624 | 1 to 588 | 588/588 (100 %) | 1 diff (99.9 %id) | ||||
BP353999 | .a | 37 to 610 | 1 to 573 | 573/573 (100 %) | 2 diff (99.7 %id) | ||||
BP354043 | .a | 37 to 612 | 1 to 582 | 582/582 (100 %) | 15 diff (97.5 %id) | ||||
DA999350 | breast, tumor tissue | .a | 35 to 371 | 2 to 338 | capped | 337/337 (100 %) | 0 diff (100 %id) | ||
DB000676 | breast, tumor tissue | .a | 60 to 602 | 2 to 545 | capped | 544/544 (100 %) | 2 diff (99.7 %id) | ||
DN999576 | .a | 46 to 644 | 1 to 598 | 598/598 (100 %) | 7 diff (98.9 %id) | ||||
DB016034 | esophageal, tumor tissue | .a | 58 to 618 | 2 to 562 | capped | 561/561 (100 %) | 1 diff (99.9 %id) | ||
DB039193 | testis | .a | 58 to 632 | 2 to 576 | capped | 575/575 (100 %) | 1 diff (99.9 %id) | ||
AU141625 | thyroid gland | .a | 38 to 821 | 2 to 788 | capped | 787/793 (99 %) | 7 diff (99.2 %id) | ||
AU159141 | thyroid gland | .a | 1824 to 2368 | 548 to 1 | 548/554 (98 %) | 15 diff (97.3 %id) | |||
BP365221 | lung | .a | 572 to 1154 | 1 to 584 | 584/584 (100 %) | 1 diff (99.9 %id) | |||
TI_154050054 | .a | 1572 to 2356 | 902 to 127 | AAA | 776/923 (84 %) | 16 diff (98.3 %id) | |||
TI_154177613 | .a | 223 to 1028 | 71 to 872 | 802/805 (99 %) | 15 diff (98.2 %id) | ||||
DB180469 | kidney, tumor tissue | .a | 34 to 580 | 2 to 548 | capped | 547/547 (100 %) | 1 diff (99.9 %id) | ||
DB185068 | liver, tumor tissue | .a | 38 to 596 | 2 to 560 | capped | 559/559 (100 %) | 1 diff (99.9 %id) | ||
BM676553 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 1786 to 2356 | 589 to 19 | AAA | 571/571 (100 %) | 0 diff (100 %id) | ||
BM713937 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 1663 to 1894 | 1 to 232 | 232/232 (100 %) | 0 diff (100 %id) | |||
BU738764 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 2009 to 2356 | 366 to 19 | AAA | 348/348 (100 %) | 0 diff (100 %id) | ||
BU620944 | cell lines, Chondrosarcoma | .a | 1640 to 2356 | 734 to 19 | AAA | 716/716 (100 %) | 1 diff (99.9 %id) | ||
DB251395 | uterus | .a | 38 to 532 | 2 to 495 | capped | 494/494 (100 %) | 2 diff (99.6 %id) | ||
AK222685 | brain | .a | 1429 to 1897 | 21 to 488 | AAA | Suspected internal deletion, this clone was ignored | 468/491 (95 %) | 4 diff (99.2 %id) | |
BQ671476 | epidermoid carcinoma, cell line, salivary gland | .a | 1429 to 1897 | 21 to 488 | 468/491 (95 %) | 4 diff (99.2 %id) | |||
BU502774 | carcinoma, cell line, Prostate | .a | 1452 to 1987 | 26 to 566 | 541/1168 (46 %) | 6 diff (99.5 %id) | |||
BU502774 | carcinoma, cell line, Prostate | .a | 1452 to 1987 | 26 to 566 | 541/1168 (46 %) | 6 diff (99.5 %id) | |||
CX788717 | human embryonic stem cells | .a | 1889 to 2647 | 1 to 759 | 759/759 (100 %) | 1 diff (99.9 %id) | |||
CV813307 | Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass | .a | 799 to 1472 | 1 to 674 | 674/675 (99 %) | 9 diff (98.7 %id) | |||
CV813307 | Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass | .a | 799 to 1472 | 1 to 674 | 674/675 (99 %) | 9 diff (98.7 %id) | |||
CF145400 | CNCAP(3)T-225 cell line, Prostate | .a | 216 to 805 | 1 to 590 | 590/590 (100 %) | 5 diff (99.2 %id) | |||
CF145400 | CNCAP(3)T-225 cell line, Prostate | .a | 216 to 805 | 1 to 590 | 590/590 (100 %) | 5 diff (99.2 %id) | |||
CF146807 | CNCAP(3)T-225 cell line, Prostate | .a | 2265 to 2533 | 2 to 271 | AAA | 270/271 (99 %) | 6 diff (97.8 %id) | ||
CF146807 | CNCAP(3)T-225 cell line, Prostate | .a | 2265 to 2533 | 2 to 271 | AAA | 270/271 (99 %) | 6 diff (97.8 %id) | ||
CF146838 | CNCAP(3)T-225 cell line, Prostate | .a | 2265 to 2533 | 2 to 271 | AAA | 270/271 (99 %) | 6 diff (97.8 %id) | ||
CF146838 | CNCAP(3)T-225 cell line, Prostate | .a | 2265 to 2533 | 2 to 271 | AAA | 270/271 (99 %) | 6 diff (97.8 %id) | ||
DA606968 | .a | 993 to 1469 | 2 to 478 | capped | 477/477 (100 %) | 1 diff (99.8 %id) | |||
TI_57196449 | .a | 33 to 803 | 32 to 807 | 776/808 (96 %) | 29 diff (96.5 %id) | ||||
TI_57174759 | .a | 44 to 817 | 28 to 800 | 773/800 (96 %) | 11 diff (98.7 %id) | ||||
TI_57167827 | .a | 44 to 923 | 30 to 907 | 878/908 (96 %) | 17 diff (98.2 %id) | ||||
TI_59385088 | .a | 43 to 781 | 63 to 802 | 740/740 (100 %) | 20 diff (97.3 %id) | ||||
TI_59381879 | .a | 935 to 1498 | 70 to 631 | 562/563 (99 %) | 3 diff (99.5 %id) | ||||
TI_59393071 | .a | 50 to 900 | 91 to 943 | 853/856 (99 %) | 18 diff (97.9 %id) | ||||
TI_59390761 | .a | 662 to 1469 | 133 to 954 | 822/822 (100 %) | 31 diff (96.3 %id) | ||||
DA621230 | Kidney | .a | 49 to 607 | 2 to 560 | capped | 559/559 (100 %) | 0 diff (100 %id) | ||
DA629534 | Kidney | .a | 1 to 571 | 3 to 573 | tiling clone, capped | 572/572 (100 %) | 0 diff (100 %id) | ||
DA648694 | .a | 38 to 577 | 2 to 541 | capped | 540/540 (100 %) | 1 diff (99.9 %id) | |||
DA651487 | .a | 38 to 577 | 2 to 546 | capped | 545/548 (99 %) | 8 diff (98.6 %id) | |||
DA655463 | .a | 47 to 609 | 2 to 564 | capped | 563/563 (100 %) | 1 diff (99.9 %id) | |||
DA661652 | .a | 35 to 594 | 2 to 565 | capped | 564/564 (100 %) | 5 diff (99.2 %id) | |||
AU280528 | .a | 55 to 614 | 1 to 560 | 560/560 (100 %) | 1 diff (99.9 %id) | ||||
NM_023078.3 | .a | 1 to 2674 | 5 to 2678 | exact | RefSeq, | 2678/2678 (100 %) | 0 diff (100 %id) | ||
AU129509 | .a | 61 to 611 | 2 to 557 | capped | 556/562 (98 %) | 15 diff (97.4 %id) | |||
AU151610 | .a | 2096 to 2674 | 573 to 1 | 573/580 (98 %) | 37 diff (93.7 %id) | ||||
DA738571 | .a | 17 to 708 | 2 to 694 | capped | 693/717 (96 %) | 6 diff (99.2 %id) | |||
DB324539 | .a | 2163 to 2674 | 512 to 1 | 512/519 (98 %) | 14 diff (97.4 %id) | ||||
DA777535 | brain | .a | 1 to 576 | 3 to 578 | capped | 577/577 (100 %) | 1 diff (99.9 %id) | ||
DA780432 | brain | .a | 1 to 572 | 2 to 573 | capped | 572/572 (100 %) | 1 diff (99.9 %id) | ||
DA876297 | Prostate | .a | 37 to 601 | 2 to 566 | capped | 565/565 (100 %) | 1 diff (99.9 %id) | ||
DA886321 | .a | 60 to 626 | 2 to 568 | capped | 567/567 (100 %) | 0 diff (100 %id) | |||
BP331008 | rectum | .a | 45 to 625 | 1 to 581 | 581/581 (100 %) | 1 diff (99.9 %id) | |||
TI_1948102508 | .a | 63 to 769 | 128 to 841 | fully sequenced, | 714/841 (84 %) | 38 diff (95.5 %id) | |||
TI_1948102509 | .a | 739 to 886 | 211 to 64 | fully sequenced, | 148/175 (84 %) | 0 diff (100 %id) | |||
TI_1948102674 | .a | 63 to 577 | 128 to 642 | fully sequenced, | 515/642 (80 %) | 8 diff (98.8 %id) | |||
TI_1948102675 | .a | 547 to 886 | 406 to 66 | fully sequenced, | 341/406 (83 %) | 0 diff (100 %id) | |||
F35951 | pectoral muscle (after mastectomy) | .a | 2082 to 2356 | 1 to 275 | AAA | 275/275 (100 %) | 2 diff (99.3 %id) | ||
DA901489 | .a | 38 to 554 | 2 to 518 | capped | 517/517 (100 %) | 0 diff (100 %id) | |||
DA901807 | .a | 49 to 552 | 2 to 507 | capped | 506/506 (100 %) | 2 diff (99.7 %id) | |||
DA904650 | .a | 49 to 612 | 2 to 565 | capped | 564/564 (100 %) | 0 diff (100 %id) | |||
DA905499 | .a | 55 to 620 | 14 to 579 | capped | 566/566 (100 %) | 0 diff (100 %id) | |||
DA918175 | small intestine | .a | 1 to 511 | 3 to 513 | capped | 512/515 (99 %) | 1 diff (99.9 %id) | ||
DA919818 | small intestine | .a | 28 to 588 | 2 to 562 | capped | 561/561 (100 %) | 1 diff (99.9 %id) | ||
DA920688 | small intestine | .a | 46 to 615 | 2 to 571 | capped | 570/570 (100 %) | 1 diff (99.9 %id) | ||
DA941030 | Spleen | .a | 43 to 623 | 2 to 582 | capped | 581/581 (100 %) | 1 diff (99.9 %id) | ||
DA945375 | Spleen | .a | 1 to 544 | 5 to 548 | capped | 547/547 (100 %) | 0 diff (100 %id) | ||
DA948173 | Spleen | .a | 28 to 598 | 2 to 574 | capped | 573/573 (100 %) | 3 diff (99.5 %id) | ||
DC391258 | Spleen | .c | 1 to 578 | 1 to 578 | 578/578 (100 %) | 0 diff (100 %id) | |||
BP353426 | .a | 37 to 624 | 1 to 588 | 588/588 (100 %) | 1 diff (99.9 %id) | ||||
BP353999 | .a | 37 to 610 | 1 to 573 | 573/573 (100 %) | 2 diff (99.7 %id) | ||||
BP354043 | .a | 37 to 612 | 1 to 582 | 582/582 (100 %) | 15 diff (97.5 %id) | ||||
DA999350 | breast, tumor tissue | .a | 35 to 371 | 2 to 338 | capped | 337/337 (100 %) | 0 diff (100 %id) | ||
DB000676 | breast, tumor tissue | .a | 60 to 602 | 2 to 545 | capped | 544/544 (100 %) | 2 diff (99.7 %id) | ||
DN999576 | .a | 46 to 644 | 1 to 598 | 598/598 (100 %) | 7 diff (98.9 %id) | ||||
DB016034 | esophageal, tumor tissue | .a | 58 to 618 | 2 to 562 | capped | 561/561 (100 %) | 1 diff (99.9 %id) | ||
DB039193 | testis | .a | 58 to 632 | 2 to 576 | capped | 575/575 (100 %) | 1 diff (99.9 %id) | ||
AU141625 | thyroid gland | .a | 38 to 821 | 2 to 788 | capped | 787/793 (99 %) | 7 diff (99.2 %id) | ||
AU159141 | thyroid gland | .a | 1824 to 2368 | 548 to 1 | 548/554 (98 %) | 15 diff (97.3 %id) | |||
BP365221 | lung | .a | 572 to 1154 | 1 to 584 | 584/584 (100 %) | 1 diff (99.9 %id) | |||
TI_154050054 | .a | 1572 to 2356 | 902 to 127 | AAA | 776/923 (84 %) | 16 diff (98.3 %id) | |||
TI_154177613 | .a | 223 to 1028 | 71 to 872 | 802/805 (99 %) | 15 diff (98.2 %id) | ||||
DB180469 | kidney, tumor tissue | .a | 34 to 580 | 2 to 548 | capped | 547/547 (100 %) | 1 diff (99.9 %id) | ||
DB185068 | liver, tumor tissue | .a | 38 to 596 | 2 to 560 | capped | 559/559 (100 %) | 1 diff (99.9 %id) | ||
BM676553 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 1786 to 2356 | 589 to 19 | AAA | 571/571 (100 %) | 0 diff (100 %id) | ||
BM676553 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 1786 to 2356 | 589 to 19 | AAA | 571/571 (100 %) | 0 diff (100 %id) | ||
BM713937 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 1663 to 1894 | 1 to 232 | 232/232 (100 %) | 0 diff (100 %id) | |||
BM713937 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 1663 to 1894 | 1 to 232 | 232/232 (100 %) | 0 diff (100 %id) | |||
BU738764 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 2009 to 2356 | 366 to 19 | AAA | 348/348 (100 %) | 0 diff (100 %id) | ||
BU738764 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 2009 to 2356 | 366 to 19 | AAA | 348/348 (100 %) | 0 diff (100 %id) | ||
BU620944 | cell lines, Chondrosarcoma | .a | 1640 to 2356 | 734 to 19 | AAA | 716/716 (100 %) | 1 diff (99.9 %id) | ||
BU620944 | cell lines, Chondrosarcoma | .a | 1640 to 2356 | 734 to 19 | AAA | 716/716 (100 %) | 1 diff (99.9 %id) | ||
DB251395 | uterus | .a | 38 to 532 | 2 to 495 | capped | 494/494 (100 %) | 2 diff (99.6 %id) |
? | Gene Summary | Gene on genome | mRNA:.a, .b, .c, .d, .e, .f, .g | Alternative mRNAs features, proteins, introns, exons, sequences | Expression Tissue | Function, regulation, related genes CI |